Hautriwaic acid is primarily investigated for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in suppressing pro-inflammatory cytokines, making it a candidate of interest in the development of therapeutics for chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. Preliminary studies suggest it may also interfere with signaling pathways involved in cellular stress responses, which could have implications in neurodegenerative conditions. Due to its natural origin and unique structure, it serves as a lead compound in the design of new bioactive molecules. Research is ongoing to evaluate its bioavailability and efficacy in in vivo models.